Dr Vigrosky is testing the effectiveness of a new drug, called Xiptoflux, which is
supposed to alleviate certain symptoms which accompany restless leg syndrome.
Dr
Vigrosky gives one group of participants, who suffer from RLS, a drug which has
already been approved by the FDA. He gives another group of participants, who suffer
from RLS, the new drug, Xiptoflux. He found no significant difference between the
new drug and the old drug in terms of the alleviation of the symptoms of restless leg
syndrome. What aspect of Dr Vigrosky's design could be improved in subsequent trials
of the study?
A) He could have compared the two drugs to a third restless leg syndrome drug
B) He could have used an experimental group
C) He could have used a placebo control group
D) He could have given the new drug to a group of people who do not suffer from
RLS
Question 2
How were the animals in the study by Terkel and Rosenblatt ( 1968 ) treated
differently?
A) amount of food
B) amount of exercise
C) type of injection
D) type of environment
Charles Darwin may be dead and gone but a recent write-in campaign has pitted him against Republican
) Intradermal drug administration: (d) the needle is removed and the puncture site is covered with
Documented Herb–Drug Interactions
Documented Herb–Drug Interactions
Common Serious Adverse Drug Reactions
A lesion called a plaque in the brain of an individual with Alzheimer disease. A ring of degeneratin